[
    "Figure 1. Alkyne-containingnatural productsand drug molecules A schematic displaying a selection of relevantnatural productsand drug molecules.",
    "Figure 2. Substrate scope of Ni-catalyzed C(sp2)–C(sp) coupling of terminal alkynes and aryl iodides Reaction conditions:1(0.5 mmol),2(0.75 mmol), NiCl2(10 mol %), 1,10-phenanthroline (15 mol %), 4-CN-pyridineN-oxide (0.75 mmol), KF (0.75 mmol), Zn (0.6 mmol), DMAc (5 mL), 60°C, N2, 48 h, isolated yield. aRun at 70°C.",
    "Figure 3. Substrate scope of Ni-catalyzed C(sp2)–C(sp) coupling of terminal alkynes and aryl bromides Reaction conditions:4(0.5 mmol),5(0.75 mmol), NiCl2(10 mol %), 1,10-phenanthroline (15 mol %), 4-CN-pyridineN-oxide (0.75 mmol), KF (0.75 mmol), Zn (0.6 mmol), DMAc (5 mL), 70°C, N2, 48 h, isolated yield.",
    "Figure 4. Product transformation of the Ni-catalyzed C(sp2)–C(sp) coupling and gram-scale reaction (A, B, and E) Reaction conditions: aryl iodides (0.5 mmol), terminal alkynes (0.75 mmol), NiCl2(10 mol %), 1,10-phenanthroline (15 mol %), 4-CN-pyridineN-oxide (0.75 mmol), KF (0.75 mmol), Zn (0.6 mmol), DMAc (5 mL), 60°C, N2, 48 h, isolated yield. (C) Reaction conditions: aryl iodide (0.5 mmol), terminal alkyne (1.5 mmol), NiCl2(10 mol %), 1,10-phenanthroline (15 mol %), 4-CN-pyridineN-oxide (0.75 mmol), KF (0.75 mmol), Zn (0.6 mmol), DMAc (5 mL), 60°C, N2, 48 h, isolated yield. (D) Reaction conditions: aryl bromide (0.5 mmol), terminal alkyne (1.5 mmol), NiCl2(10 mol %), 1,10-phenanthroline (15 mol %), 4-CN-pyridineN-oxide (0.75 mmol), KF (0.75 mmol), Zn (0.6 mmol), DMAc (5 mL), 70°C, N2, 48 h, isolated yield. (F) Reaction conditions: aryl iodide (5 mmol), terminal alkyne (7.5 mmol), NiCl2(10 mol %), 1,10-phenanthroline (15 mol %), 4-CN-pyridineN-oxide (7.5 mmol), KF (7.5 mmol), Zn (6 mmol), DMAc (50 mL), 60°C, N2, 48 h, isolated yield.",
    "Figure 5. Selectivity of Ni-catalyzed C(sp2)–C(sp) coupling of iodide vs. bromide Standard conditions: aryl halide (0.5 mmol), terminal alkynes (0.75 mmol), NiCl2(10 mol %), 1,10-phenanthroline (15 mol %), 4-CN-pyridineN-oxide (0.75 mmol), KF (0.75 mmol), Zn (0.6 mmol), DMAc (5 mL), N2, 48 h, isolated yield.",
    "Figure 6.Mechanistic studies (A) Ni(COD)2(0.5 mmol), 1,10-phenanthroline (0.5 mmol),4l(0.55 mmol), super dry THF (7 mL). (B)4l(0.5 mmol),5l(0.75 mmol),22(10 mol %), 4-CN-pyridineN-oxide (0.75 mmol), KF (0.75 mmol), Zn (0.6 mmol), DMAc (5 mL), 70°C, N2, 48 h, isolated yield. (C)22(0.1 mmol),5l(0.15 mmol), 4-CN-pyridineN-oxide (0.15 mmol), KF (0.15 mmol), DMAc (1 mL), 70°C, N2, 48 h, isolated yield. (D)4l(0.5 mmol),5l(0.75 mmol), NiCl2(10 mol %), 1,10-phenanthroline (15 mol %), KF (0.75 mmol), Zn (0.6 mmol), KOtBu (0.75 mmol), DMAc (5 mL), 70°C, N2, 48 h, isolated yield. (E)5l(0.75 mmol), KOtBu (0.75 mmol) (left equation),4l(0.5 mmol), NiCl2(10 mol %), 1,10-phenanthroline (15 mol %), KF (0.75 mmol), Zn (0.6 mmol), DMAc (5 mL), 70°C, N2, 48 h, isolated yield (right equation).",
    "Figure 7. DFT-calculated free-energy profiles Profiles of Ni-catalyzed Sonogashira coupling and the optimized geometries of transition states",
    "Scheme 1. Development of transition-catalyzedSonogashira reactions (A) Singlepalladiumcatalyzed Sonogashira reactions: two-step method, air- and moisture-sensitive lithiumacetylidesare required to be prepared in advance. (B) Single copper catalyzed Sonogashira reactions: high temperature promoted reactions. (C) This work: single nickel catalyzed Sonogashira reactions: mild reaction conditions.",
    "Table 1. Optimization of Ni-catalyzed C(sp2)–C(sp) coupling Reaction conditions: 1a (0.5 mmol), 2a (0.75 mmol), NiCl 2 (10 mol %), ligand (15 mol %), base (0.75 mmol), KF (0.75 mmol), Zn (0.6 mmol), DMAc (5 mL), 60°C, N 2 , 48 h, isolated yield. NC, no conversion."
]